Computer systems for the prediction of xenobiotic metabolism

SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules

Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436 · see citing works

Drug Metabolism: Chemical and Biochemical Aspects

Testa, B., & Jenner, P. (1976) · Medical Entomology and Zoology · Cited by 308 · see citing works

Knowledge-Based Expert Systems for Toxicity and Metabolism Prediction: DEREK, StAR and METEOR

Greene, N., Judson, P. N., Langowski, J. J., & Marchant, C. A. (1999) · SAR and QSAR in environmental research · doi:10.1080/10629369908039182 · Cited by 251 · see citing works

QSAR in Environmental Toxicology - II

(1987) · Springer eBooks · doi:10.1007/978-94-009-3937-0 · Cited by 248 · see citing works

Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites.

Ekins, S., de Groot, M. J., & Jones, J. P. (2001) · PubMed · Cited by 202 · see citing works

META. 1. A Program for the Evaluation of Metabolic Transformation of Chemicals

Klopman, G., Dimayuga, M., & Talafous, J. (1994) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00022a014 · Cited by 169 · see citing works

Properties of cytochrome P450 isoenzymes and their substrates part 2: properties of cytochrome P450 substrates

Smith, D. A., Ackland, M. J., & Jones, B. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01085-4 · Cited by 121 · see citing works

META. 2. A Dictionary Model of Mammalian Xenobiotic Metabolism

Talafous, J., Sayre, L. M., Mieyal, J. J., & Klopman, G. (1994) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00022a015 · Cited by 99 · see citing works

Properties of cytochrome P450 isoenzymes and their substrates Part 1: active site characteristics

Smith, D. A., Ackland, M. J., & Jones, B. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01081-7 · Cited by 91 · see citing works

Quantitative Structure-Activity Relationships of Cytochrome P-450

Hansch, C. H., & Zhang, L. (1993) · Drug Metabolism Reviews · doi:10.3109/03602539308993972 · Cited by 75 · see citing works

Predicting metabolic pathways by logic programming

Darvas, F. (1988) · Journal of Molecular Graphics · doi:10.1016/0263-7855(88)85004-5 · Cited by 70 · see citing works

META. 3. A Genetic Algorithm for Metabolic Transform Priorities Optimization

Klopman, G., Tu, M., & Talafous, J. (1997) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci9601123 · Cited by 62 · see citing works

Quantitative Structure-Activity Relationships in Substrates, Inducers, and Inhibitors of Cytochrome P4501 (CYP1)

Lewis, D. F. V. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709037593 · Cited by 54 · see citing works

Metabolexpert: An Expert System for Predicting Metabolism of Substances

Darvas, F. (1987) · Springer eBooks · doi:10.1007/978-94-009-3937-0_7 · Cited by 47 · see citing works

COMPACT: a structural approach to the modelling of cytochromes P450 and their interactions with xenobiotics

Lewis, D. F. (2001) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.363 · Cited by 41 · see citing works

An Improved and Updated Version of the Compact Procedure for the Evaluation of P450-Mediated Chemical Activation

Lewis, D. F., Ioannides, C., & Parke, D. V. W. (1998) · Drug Metabolism Reviews · doi:10.3109/03602539808996328 · Cited by 40 · see citing works

Molecular modelling and quantitative structure-activity relationship studies on the interaction of omeprazole with cytochrome P450 isozymes

Lewis, D. F., & Lake, B. G. (1998) · Toxicology · doi:10.1016/s0300-483x(97)00159-5 · Cited by 38 · see citing works

A retrospective evaluation of COMPACT predictions of the outcome of NTP rodent carcinogenicity testing.

Lewis, D. F. V., Ioannides, C., & Parke, D. V. W. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103178 · Cited by 35 · see citing works

META 4. Prediction of the metabolism of polycyclic aromatic hydrocarbons

Klopman, G., Tu, M., & Fan, B. T. (1999) · Theoretical Chemistry Accounts · doi:10.1007/s002140050470 · Cited by 25 · see citing works

Further evaluation of COMPACT, the molecular orbital approach for the prospective safety evaluation of chemicals

Lewis, D. F. V., Ioannides, C., & Parke, D. V. W. (1998) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(97)00145-9 · Cited by 22 · see citing works

QSAR in environmental toxicology

Netter, K. J. (1985) · Toxicology · doi:10.1016/0300-483x(85)90149-0 · Cited by 22 · see citing works

Using New Reasoning Technology in Chemical Information Systems

Judson, P. N., Fox, J., & Krause, P. J. (1996) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci9500905 · Cited by 17 · see citing works

Representation of Chemical Structures in Knowledge-Based Systems: The StAR System

Tonnelier, C., Fox, J., Judson, P. N., Krause, P., Pappas, N., & Patel, M. L. (1997) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci960094p · Cited by 15 · see citing works

ADMET in silico modelling: towards prediction paradise?

Waterbeemd, H. V. D., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,894 · see citing works

In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling

Ekins, S., Mestres, J., & Testa, B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707305 · Cited by 721 · see citing works

The food metabolome: a window over dietary exposure

Scalbert, A., Brennan, L., Manach, C., Andres-Lacueva, C., Dragsted, L. O., Draper, J., Rappaport, S. M., van der Hooft, J. J., & Wishart, D. S. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.076133 · Cited by 519 · see citing works

A Framework for Assessing Inter-individual Variability in Pharmacokinetics Using Virtual Human Populations and Integrating General Knowledge of Physical Chemistry, Biology, Anatomy, Physiology and Genetics: A Tale of ‘Bottom-Up’ vs ‘Top-Down’ Recognition of Covariates

Jamei, M., Dickinson, G. L., & Rostami‐Hodjegan, A. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.53 · Cited by 368 · see citing works

In Silico Tools for Sharing Data and Knowledge on Toxicity and Metabolism: Derek for Windows, Meteor, and Vitic

Marchant, C. A., Briggs, K. A., & Long, A. (2008) · Toxicology Mechanisms and Methods · doi:10.1080/15376510701857320 · Cited by 344 · see citing works

Bioremediation through microbes: systems biology and metabolic engineering approach

Dangi, A. K., Sharma, B., Hill, R. T., & Shukla, P. (2018) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2018.1500997 · Cited by 322 · see citing works

Metabolic Stability for Drug Discovery and Development

Masimirembwa, C. M., Bredberg, U., & Andersson, T. B. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342060-00002 · Cited by 230 · see citing works

The complex links between dietary phytochemicals and human health deciphered by metabolomics

Manach, C., Hubert, J., Llorach, R., & Scalbert, A. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800516 · Cited by 218 · see citing works

Recent Development and Application of Virtual Screening in Drug Discovery: An Overview

Hou, T., & Xu, X. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452721 · Cited by 187 · see citing works

The University of Minnesota Biocatalysis/Biodegradation Database: the first decade

Ellis, L. B. M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gkj076 · Cited by 186 · see citing works

ADME–Tox in drug discovery: integration of experimental and computational technologies

Yu, H., & Adedoyin, A. B. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02828-9 · Cited by 179 · see citing works

Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets

Coen, D. M., & Schaffer, P. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1065 · Cited by 165 · see citing works

Structure‐based Drug Metabolism Predictions for Drug Design

Sun, H., & Scott, D. O. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00899.x · Cited by 164 · see citing works

PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment

Bessems, J. G. M., Loizou, G. D., Krishnan, K., M.A., H. J. C. I., Bernasconi, C., Bois, F. Y., Coecke, S., Collnot, E.-M., Diembeck, W., Farcal, L. R., et al. (2013) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2013.11.008 · Cited by 152 · see citing works

New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites

Diao, X., & Huestis, M. A. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00109 · Cited by 150 · see citing works

Prediction of Cytochrome P450 3A4, 2D6, and 2C9 Inhibitors and Substrates by Using Support Vector Machines

Yap, C. W., & Chen, Y. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci0500536 · Cited by 148 · see citing works

Computational Strategies for Metabolite Identification in Metabolomics

Wishart, D. S. (2009) · Bioanalysis · doi:10.4155/bio.09.138 · Cited by 120 · see citing works

Site of metabolism prediction for six biotransformations mediated by cytochromes P450

Zheng, M., Luo, X., Shen, Q., Wang, Y., Du, Y., Zhu, W., & Jiang, H. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp140 · Cited by 115 · see citing works

Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates

Jónsdóttir, S. Ó., Jørgensen, F. S., & Brunak, S. (2005) · Computer applications in the biosciences · doi:10.1093/bioinformatics/bti314 · Cited by 108 · see citing works

The Biochemistry of Drug Metabolism – An Introduction

Testa, B., & Krämer, S. D. (2006) · Chemistry & Biodiversity · doi:10.1002/cbdv.200690111 · Cited by 104 · see citing works

Predicting human liver microsomal stability with machine learning techniques

Sakiyama, Y., Yuki, H., Moriya, T., Hattori, K., Suzuki, M., Shimada, K., & Honma, T. (2007) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2007.06.005 · Cited by 96 · see citing works

Computational prediction of human drug metabolism

Ekins, S., Andreyev, S., Ryabov, A., Kirillov, E., Rakhmatulin, E. A., Bugrim, A. E., & Nikolskaya, T. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.2.303 · Cited by 86 · see citing works

Systematic Analysis of Enzyme-Catalyzed Reaction Patterns and Prediction of Microbial Biodegradation Pathways

Oh, M., Yamada, T., Hattori, M., Goto, S., & Kanehisa, M. I. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700006f · Cited by 85 · see citing works

E-zyme: predicting potential EC numbers from the chemical transformation pattern of substrate-product pairs

Yamanishi, Y., Hattori, M., Kotera, M., Goto, S., & Kanehisa, M. I. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp223 · Cited by 83 · see citing works

Microbial Pathway Prediction: A Functional Group Approach

Hou, B. K., Wackett, L. P., & Ellis, L. B. M. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034018f · Cited by 81 · see citing works

Predicting Drug Metabolism - An Evaluation of the Expert SystemMETEOR

Testa, B., Balmat, A.-L., Long, A., & Judson, P. N. (2005) · Chemistry & Biodiversity · doi:10.1002/cbdv.200590064 · Cited by 78 · see citing works

Encoding microbial metabolic logic: predicting biodegradation

Hou, B. K., Ellis, L. B. M., & Wackett, L. P. (2004) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-004-0144-7 · Cited by 76 · see citing works

An Overall Strategy for the Testing of Chemicals for Human Hazard and Risk Assessment under the EU REACH System

Combes, R. D., Barratt, M. D., & Balls, M. (2003) · Alternatives to Laboratory Animals · doi:10.1177/026119290303100103 · Cited by 74 · see citing works

Role of Biotransformation Studies in Minimizing Metabolism-Related Liabilities in Drug Discovery

Shu, Y., Johnson, B. M., & Yang, T. J. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9016-9 · Cited by 74 · see citing works

Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs

Crivori, P., & Poggesi, I. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.03.003 · Cited by 74 · see citing works

Definition and system implementation of strategies for method development of chiral separations in normal- or reversed-phase liquid chromatography using polysaccharide-based stationary phases

Matthijs, N., Perrin, C., Maftouh, M., Massart, D. L., & Heyden, Y. V. (2004) · Journal of Chromatography A · doi:10.1016/j.chroma.2004.04.040 · Cited by 72 · see citing works

The In Silico Drug Discovery Toolbox: Applications in Lead Discovery and Optimization

Bruno, A., Costantino, G., Sartori, L., & Radi, M. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666171107101035 · Cited by 70 · see citing works

In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry

Tyrkkö, E., Pelander, A., Ketola, R. A., & Ojanperä, I. A. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-7137-1 · Cited by 69 · see citing works

Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2

Zak, M., Hurley, C. A., Ward, S. I., Bergeron, P., Barrett, K., Balázs, M., Blair, W. S., Bull, R., Chakravarty, P., Chang, C. C., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4004895 · Cited by 67 · see citing works

In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9

Nembri, S., Grisoni, F., Consonni, V., & Todeschini, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060914 · Cited by 66 · see citing works

Bioinformatics in Drug Development and Assessment

Wishart, D. S. (2005) · Drug Metabolism Reviews · doi:10.1081/dmr-55225 · Cited by 64 · see citing works

Computational Tools And Resources For Metabolism-Related Property Predictions. 1. Overview Of Publicly Available (Free And Commercial) Databases And Software

Peach, M. L., Zakharov, A. V., Liu, R., Pugliese, A., Tawa, G. J., Wallqvist, A., & Nicklaus, M. C. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.150 · Cited by 63 · see citing works

Introduction to Cheminformatics

Wishart, D. S. (2007) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1401s18 · Cited by 59 · see citing works

Do Fukui Function Maxima Relate to Sites of Metabolism? A Critical Case Study

Beck, M. E. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049687n · Cited by 59 · see citing works

Review of the Availability of In Vitro and In Silico Methods for Assessing Dermal Bioavailability

Coralie, D., Prieto, P., Asturiol, D., & Worth, A. P. (2015) · Applied In Vitro Toxicology · doi:10.1089/aivt.2015.0003 · Cited by 53 · see citing works

QSARs for PBPK modelling of environmental contaminants

Peyret, T., & Krishnan, K. (2011) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2010.548351 · Cited by 49 · see citing works

Bridging cheminformatic metabolite prediction and tandem mass spectrometry

Anari, M. R., & Baillie, T. A. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03445-8 · Cited by 49 · see citing works

Evaluation of three state-of-the-art metabolite prediction software packages (Meteor, MetaSite, and StarDrop) through independent and synergistic use

T’jollyn, H., Boussery, K., Mortishire-Smith, R. J., Coe, K., De Boeck, B., Van Bocxlaer, J. F., & Mannens, G. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.039982 · Cited by 48 · see citing works

Modeling Biotransformation Reactions by Combined Quantum Mechanical / Molecular Mechanical Approaches: From Structure to Activity

Ridder, L., & Mulholland, A. J. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452005 · Cited by 46 · see citing works

QSAR Analysis of the Inhibition of Recombinant CYP 3A4 Activity by Structurally Diverse Compounds Using a Genetic Algorithm-Combined Partial Least Squares Method

Wanchana, S., Yamashita, F., & Hashida, M. (2003) · Pharmaceutical Research · doi:10.1023/a:1025702009611 · Cited by 46 · see citing works

In Silico Enzymatic Synthesis of a 400 000 Compound Biochemical Database for Nontargeted Metabolomics

Menikarachchi, L. C., Hill, D. W., Hamdalla, M. A., Măndoiu, I., & Grant, D. F. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400368v · Cited by 45 · see citing works

Fromin vivotoin vitro/in silicoADME: progress and challenges

Waterbeemd, H. V. D. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.1.1 · Cited by 44 · see citing works

An evaluation of the latestin vitrotools for drug metabolism studies

Costa, A., Sarmento, B. F. C. C., & Seabra, V. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.857402 · Cited by 42 · see citing works

Classification of Cytochrome P450 Activities Using Machine Learning Methods

Hammann, F., Gutmann, H., Baumann, U., Helma, C., & Drewe, J. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900217x · Cited by 41 · see citing works

Predicting Biotransformation Potential from Molecular Structure

Borodina, Y. V., Sadym, A., Filimonov, D. A., Blinova, V. G., Dmitriev, A. V., & Poroikov, V. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034078l · Cited by 41 · see citing works

Methods for Predicting Human Drug Metabolism

Jolivette, L. J., & Ekins, S. (2006) · Advances in clinical chemistry · doi:10.1016/s0065-2423(06)43005-5 · Cited by 41 · see citing works

Assays for the Identification and Prioritization of Drug Candidates for Spinal Muscular Atrophy

Cherry, J. J., Kobayashi, D. T., Lynes, M. M., Naryshkin, N. N., Tiziano, F. D., Zaworski, P. G., Rubin, L. L., & Jarecki, J. (2014) · Assay and Drug Development Technologies · doi:10.1089/adt.2014.587 · Cited by 39 · see citing works

Structure-based methods for the prediction of drug metabolism

Madden, J. C., & Cronin, M. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.4.545 · Cited by 39 · see citing works

Preclinical Development Handbook

(2007) · Wiley eBooks · doi:10.1002/9780470249055 · Cited by 38 · see citing works

Elucidating degradation mechanisms of florfenicol in soil by stable-isotope assisted nontarget screening

Qiu, M., Hu, A., Huang, Y. M., Zhao, Y. F., He, Y., Xu, J. M., & Lu, Z. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.123974 · Cited by 37 · see citing works

Prediction of metabolic reactions based on atomic and molecular properties of small-molecule compounds

Mu, F., Ünkefer, C. J., Unkefer, P. J., & Hlavacek, W. S. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr177 · Cited by 36 · see citing works

Nontargeted screening method for veterinary drugs and their metabolites based on fragmentation characteristics from ultrahigh-performance liquid chromatography-high-resolution mass spectrometry

Liang, W., Zheng, F., Chen, T., Zhang, X., Xia, Y., Li, Z., Lu, X., Zhao, C., & Xu, G. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.130928 · Cited by 35 · see citing works

Highly Accurate Detection and Identification Methodology of Xenobiotic Metabolites Using Stable Isotope Labeling, Data Mining Techniques, and Time-Dependent Profiling Based on LC/HRMS/MS

Takahashi, M., Izumi, Y., Iwahashi, F., Nakayama, Y., Iwakoshi, M., Nakao, M., Yamato, S., Fukusaki, E., & Bamba, T. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01388 · Cited by 34 · see citing works

Multiple Pharmacokinetic Parameter Prediction for a Series of Cephalosporins

Turner, J., Maddalena, D. J., Cutler, D. J., & Agatonović-Kuštrin, S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10314 · Cited by 32 · see citing works

Computational methods for early predictive safety assessment from biological and chemical data

Nigsch, F., Lounkine, E., McCarren, P. R., Cornett, B., Glick, M., Azzaoui, K., Urbán, L., Marc, P., Müller, A., Hahne, F., et al. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.632632 · Cited by 30 · see citing works

The challenges of in silico contributions to drug metabolism in lead optimization

Vaz, R. J., Zamora, I., Li, Y., Reiling, S., Shen, J., & Cruciani, G. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.499123 · Cited by 30 · see citing works

In silico toxicity profiling of natural product compound libraries from African flora with anti-malarial and anti-HIV properties

Onguéné, P. A., Simoben, C. V., Fotso, G. W., Andrae‐Marobela, K., Khalid, S. A., Ngadjui, B. T., Meva’à, L. M., & Ntie‐Kang, F. (2017) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2017.12.002 · Cited by 29 · see citing works

Quantitative structure-activity relationships for predicting metabolism and modeling cytochrome P450 enzyme activities

Long, A., & Walker, J. D. (2003) · Environmental Toxicology and Chemistry · doi:10.1897/01-480 · Cited by 29 · see citing works

In-Silico Modeling in Drug Metabolism and Interaction: Current Strategies of Lead Discovery

Roy, H., & Nandi, S. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190903155935 · Cited by 28 · see citing works

Assessment of the metabolic stability of the methyl groups in heterocyclic compounds using CH bond dissociation energies: Effects of diverse aromatic groups on the stability of methyl radicals

Zhao, S., Liu, L., Fu, Y., & Guo, Q. (2004) · Journal of Physical Organic Chemistry · doi:10.1002/poc.856 · Cited by 28 · see citing works

Biochemical Reaction Network Modeling: Predicting Metabolism of Organic Chemical Mixtures

Mayeno, A. N., Yang, R. S. H., & Reisfeld, B. (2005) · Environmental Science & Technology · doi:10.1021/es0479991 · Cited by 28 · see citing works

An efficient algorithm for de novo predictions of biochemical pathways between chemical compounds

Nakamura, M., Hachiya, T., Saitō, Y., Sato, K., & Sakakibara, Y. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-s17-s8 · Cited by 27 · see citing works

A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discovery

Aliagas, I., Gobbi, A., Heffron, T. P., Lee, M., Ortwine, D. F., Zak, M., & Khojasteh, S. C. (2015) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-015-9838-3 · Cited by 27 · see citing works

3.9. Toxicokinetics and Metabolism

Coecke, S., Blaauboer, B. J., Elaut, G., Freeman, S., Freidig, A. P., Gensmantel, N. P., Hoet, P., Kapoulas, V. M., Ladstetter, B., Langley, G., et al. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503301s15 · Cited by 27 · see citing works

Current methodology for the assessment of ADME-Tox properties on drug candidate molecules

Veulens, A. D. L. N., & Rodríguez, R. (2008) · Biotecnología aplicada · Cited by 26 · see citing works

Introduction to Cheminformatics

Wishart, D. S. (2016) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1401s53 · Cited by 25 · see citing works

Prediction of oxidoreductase-catalyzed reactions based on atomic properties of metabolites

Mu, F., Unkefer, P. J., Ünkefer, C. J., & Hlavacek, W. S. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl535 · Cited by 24 · see citing works

Evaluation of an integrated in vitro–in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability

Cai, H., Stoner, C. L., Reddy, A., Freiwald, S., Smith, D., Winters, R. T., Stankovic, C. J., & Surendran, N. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.11.002 · Cited by 24 · see citing works

Combined Computational Metabolite Prediction and Automated Structure-Based Analysis of Mass Spectrometric Data

Stranz, D. D., Miao, S., Campbell, S., Maydwell, G., & Ekins, S. (2008) · Toxicology Mechanisms and Methods · doi:10.1080/15376510701857189 · Cited by 23 · see citing works

Eliciting Possible Reaction Equations and Metabolic Pathways Involving Orphan Metabolites

Kotera, M., McDonald, A. G., Boyce, S., & Tipton, K. F. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800213g · Cited by 22 · see citing works

Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target

Henley, Z. A., Amour, A., Barton, N., Bantscheff, M., Bergamini, G., Bertrand, S. M., Convery, M. A., Down, K. D., Dümpelfeld, B., Edwards, C. D., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01585 · Cited by 22 · see citing works

Review of QSAR Models and Software Tools for predicting Biokinetic Properties

Mostrąg, A., & Andrew, W. (2010) · Joint Research Centre (European Commission) · doi:10.2788/94537 · Cited by 22 · see citing works

Substrate selectivity of human intestinal UDP-glucuronosyltransferases (UGTs):in silicoandin vitroinsights

Tripathi, S. P., Bhadauriya, A., Patil, A., & Sangamwar, A. T. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.767345 · Cited by 20 · see citing works

ADMET tools: Prediction and assessment of chemical ADMET properties of NCEs

Silakari, O., & Singh, P. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820546-4.00014-3 · Cited by 19 · see citing works

Improving ADMET Prediction Accuracy for Candidate Drugs: Factors to Consider in QSPR Modeling Approaches

Chen, M., Yang, J., Tang, C., Lü, X., Zheng, W., Liu, Y., Yu, P., & Li, H. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266280005231207105900 · Cited by 18 · see citing works

Advancements in Predictive In Silico Models for ADME

Chohan, K. K., Paine, S. W., & Waters, N. J. (2008) · Current Chemical Biology · doi:10.2174/187231308785739747 · Cited by 18 · see citing works

The Use of Expert Systems for Toxicity Prediction

Combes, R. D., & Rodford, R. (2004) · CRC Press eBooks · doi:10.1201/9780203642627.ch9 · Cited by 18 · see citing works

Mechanistic‐Based Descriptors for QSAR Study of Psychotropic Drug Toxicity

Esteki, M., & Khayamian, T. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00718.x · Cited by 15 · see citing works

Natural modulators of nonalcoholic fatty liver disease: Mode of action analysis and in silico ADME-Tox prediction

Sharif, M. A., Alov, P., Vitcheva, V., Diukendjieva, A., Mori, M., Botta, B., Tsakovska, I., & Pajeva, I. K. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.10.013 · Cited by 15 · see citing works

Prediction of Drug-Like Molecular Properties

Jalaie, M., Arimoto, R., Gifford, E., Schefzick, S., & Waller, C. L. (2004) · Methods in molecular biology · doi:10.1385/1-59259-802-1:449 · Cited by 15 · see citing works

QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy

Ramos, E., Palomino‐Antolín, A., Bartolini, M., Iriepa, I., Moraleda, I., Diez‐Iriepa, D., Samadi, A., Cortina, C. V., Chioua, M., Egea, J., et al. (2019) · Molecules · doi:10.3390/molecules24081503 · Cited by 14 · see citing works

Prediction of Pharmacokinetic Parameters in Drug Design and Toxicology

Duffy, J. C. (2004) · CRC Press eBooks · doi:10.1201/9780203642627.ch11 · Cited by 14 · see citing works

Efficient Strategies for Lead Optimization by Simultaneously Addressing Affinity, Selectivity and Pharmacokinetic Parameters

Baringhaus, K. H., & Matter, H. (2007) · Wiley eBooks · doi:10.1002/9783527619368.ch19 · Cited by 14 · see citing works

Principles of Drug Metabolism

Testa, B. (2010) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc033.pub2 · Cited by 14 · see citing works

RD-Metabolizer: an integrated and reaction types extensive approach to predict metabolic sites and metabolites of drug-like molecules

Meng, J., Li, S., Liu, X., Zheng, M., & Li, H. (2017) · Chemistry Central Journal · doi:10.1186/s13065-017-0290-4 · Cited by 13 · see citing works

IDENTIFICATION OF GLUTATHIONE-DERIVED METABOLITES FROM AN IP RECEPTOR ANTAGONIST

Fitch, W. L., Berry, P. W., Tu, Y., Tabatabaei, A., Lowrie, L., Lopez‐Tapia, F., Liu, Y., Nitzan, D., Masjedizadeh, M. R., & Varadarajan, A. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000471 · Cited by 12 · see citing works

Prediction of human clearance (CL) and volume of distribution (VD)

Keldenich, J. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.10.007 · Cited by 12 · see citing works

Modeling and Informatics in Drug Design

Bharatam, P. V., Khanna, S., & Francis, S. M. (2007) · Wiley eBooks · doi:10.1002/9780470249031.ch1 · Cited by 12 · see citing works

In silico and in vivo studies of Astragalus glycyphylloides saponin(s) with relevance to metabolic syndrome modulation

Sharif, M. A., Vitcheva, V., Simeonova, R., Krasteva, I., Manov, V., Alov, P., Popov, G., Shkondrov, A., & Pajeva, I. K. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.05.032 · Cited by 11 · see citing works

QSAR classification of metabolic activation of chemicals into covalently reactive species

Liew, C. Y., Pan, C., Tan, A., Ang, K. X. M., & Yap, C. W. (2012) · Molecular Diversity · doi:10.1007/s11030-012-9364-3 · Cited by 11 · see citing works

Metabolic pathway prediction based on inclusive relation between cyclic substructures

Tanaka, K., Nakamura, K., Saito, T., Osada, H., Hirai, A. M., Takahashi, H., Kanaya, S., & Altaf‐Ul‐Amin, M. (2009) · Plant Biotechnology · doi:10.5511/plantbiotechnology.26.459 · Cited by 10 · see citing works

Suspect and nontarget screening of pesticides and their transformation products in agricultural products using liquid chromatography–high-resolution mass spectrometry

Chen, T., Zhang, Y., Wang, Y., Liang, W., Yan, Z., Lu, X., Liu, X., Zhao, C., & Xu, G. (2024) · Talanta · doi:10.1016/j.talanta.2024.127154 · Cited by 9 · see citing works

Computer-Based Methods for the Prediction of Chemical Metabolism and Biotransformation within Biological Organisms

Payne, M. (2004) · CRC Press eBooks · doi:10.1201/9780203642627.ch10 · Cited by 8 · see citing works

Skin metabolism established with the use of MetaSite for selected retinoids employed in topical and systemic treatment of various skin disorders and found in cosmeceuticals

Słoczyńska, K., Gunia‐Krzyżak, A., Żelaszczyk, D., Waszkielewicz, A. M., & Marona, H. (2015) · Acta Biochimica Polonica · doi:10.18388/abp.2014_891 · Cited by 7 · see citing works

ADME/Tox Properties and Biochemical Interactions of Silybin Congeners: In silico Study

Diukendjieva, A., Sharif, M. A., Alov, P., Pencheva, T., Tsakovska, I., & Pajeva, I. K. (2017) · Natural Product Communications · doi:10.1177/1934578x1701200208 · Cited by 7 · see citing works

Development of in silico models for the prediction of toxicity incorporating ADME information

Piechota, P. (2016) · Liverpool John Moores University · doi:10.24377/ljmu.t.00004554 · Cited by 4 · see citing works

ADMET in silico modelling: towards prediction paradise?

Waterbeemd, H. V. D., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,894 · see citing works

Computational prediction of human drug metabolism

Ekins, S., Andreyev, S., Ryabov, A., Kirillov, E., Rakhmatulin, E. A., Bugrim, A. E., & Nikolskaya, T. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.2.303 · Cited by 86 · see citing works

Computer-Assisted Methods in Chemical Toxicity Prediction

Mohan, C. G., Gandhi, T., Garg, D., & Shinde, R. N. (2007) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955707780619554 · Cited by 74 · see citing works

In Silico Toxicokinetics

Chakraborty, S., Boyina, H. K., Mitta, R., & Nayaka, R. (2026) · CRC Press eBooks · doi:10.1201/9781003666844-10